We report the initial results from a phase I clinical trial for ALS. We transplanted GMP-grade, fetal human neural stem cells from natural in utero death (hNSCs) into the anterior horns of the spinal cord to test for the safety of both cells and neurosurgical procedures in these patients. The trial was approved by the Istituto Superiore di Sanità and the competent Ethics Committees and was monitored by an external Safety Board.

Human neural stem cell transplantation in ALS: initial results from a phase I trial

MASIERO, STEFANO;CIMA, VALENTINA;GAIANI, ALESSANDRA;SORARU', GIANNI;
2015

Abstract

We report the initial results from a phase I clinical trial for ALS. We transplanted GMP-grade, fetal human neural stem cells from natural in utero death (hNSCs) into the anterior horns of the spinal cord to test for the safety of both cells and neurosurgical procedures in these patients. The trial was approved by the Istituto Superiore di Sanità and the competent Ethics Committees and was monitored by an external Safety Board.
File in questo prodotto:
File Dimensione Formato  
mazzini.pdf

accesso aperto

Descrizione: articolo principale
Tipologia: Published (publisher's version)
Licenza: Creative commons
Dimensione 3.26 MB
Formato Adobe PDF
3.26 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3196425
Citazioni
  • ???jsp.display-item.citation.pmc??? 54
  • Scopus 140
  • ???jsp.display-item.citation.isi??? 132
social impact